Literature DB >> 4944804

Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.

W H Traub, E A Raymond.   

Abstract

During 10 months, 155 isolates of Serratia marcescens were cultured from 105 patients, of whom 49 were considered to have significant infection. The 155 isolates were typed by bacteriocin sensitivity, and 137 (88.4%) were assigned to 37 provisional bacteriocin groups; 18 isolates were nontypable. No major outbreaks of nosocomial infection were demonstrable; however, there were four chronologically separate minor episodes of cross-infection that involved two or three patients per room or unit, respectively.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4944804      PMCID: PMC376485          DOI: 10.1128/am.22.6.1058-1063.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  23 in total

1.  Identification of Serratia occurring in man and animals.

Authors:  M FULTON; C E FORNEY; E LEIFSON
Journal:  Can J Microbiol       Date:  1959-06       Impact factor: 2.419

2.  Serratia marcescens. A pathogen of increasing clinical importance.

Authors:  J T Davis; E Foltz; W S Blakemore
Journal:  JAMA       Date:  1970-12-21       Impact factor: 56.272

3.  Identification of Enterobacteriaceae in the clinical microbiology laboratory.

Authors:  W H Traub; E A Raymond; J Linehan
Journal:  Appl Microbiol       Date:  1970-09

4.  Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak.

Authors:  C V Sanders; J P Luby; W G Johanson; J A Barnett; J P Sanford
Journal:  Ann Intern Med       Date:  1970-07       Impact factor: 25.391

5.  An outbreak of Serratia marcescens, and its control.

Authors:  H A Cabrera
Journal:  Arch Intern Med       Date:  1969-06

6.  Nonpigmented Serratia marcescens.

Authors:  E Clayton; A Von Graevenitz
Journal:  JAMA       Date:  1966-09-26       Impact factor: 56.272

Review 7.  The so-called "Paracolon" bacteria. A bacteriologic and clinical reappraisal.

Authors:  B N Fields; M M Uwaydah; L J Kunz; M N Swartz
Journal:  Am J Med       Date:  1967-01       Impact factor: 4.965

8.  Upper respiratory tract carriage of gram-negative enteric bacilli by hospital personnel.

Authors:  J J Rahal; R H Meade; C M Bump; A J Reinauer
Journal:  JAMA       Date:  1970-10-26       Impact factor: 56.272

9.  Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens.

Authors:  W H Traub; E A Raymond; T S Startsman
Journal:  Appl Microbiol       Date:  1971-05

10.  Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.

Authors:  J N Wilfert; F F Barrett; W H Ewing; M Finland; E H Kass
Journal:  Appl Microbiol       Date:  1970-02
View more
  9 in total

1.  [Antibody detection in infections with Serratia marcescens (author's transl)].

Authors:  V Freitag; F H Caselitz
Journal:  Infection       Date:  1975       Impact factor: 3.553

2.  Serotyping of Serratia marcescens: evaluation of Le Minor's H-immobilization test and description of three new flagellar H antigens.

Authors:  W H Traub; I Kleber
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

3.  Ribotyping for use in studying molecular epidemiology of Serratia marcescens: comparison with biotyping.

Authors:  H Chetoui; E Delhalle; P Osterrieth; D Rousseaux
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

4.  Biotyping of Serratia marcescens and its use in epidemiological studies.

Authors:  P A Grimont; F Grimont
Journal:  J Clin Microbiol       Date:  1978-07       Impact factor: 5.948

5.  Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.

Authors:  W H Traub
Journal:  Appl Microbiol       Date:  1972-05

6.  Bacteriocin typing of Serratia marcescens isolates of known serotype-group.

Authors:  W H Traub
Journal:  Appl Microbiol       Date:  1972-05

7.  Comparison of two methods for bacteriocin typing of Serratia marcescens.

Authors:  P S Lai; Y F Ngeow; S D Puthucheary; C W Wang
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

8.  Bacteriophage typing of clinically isolated Serratia marcescens.

Authors:  R L Hamilton; W J Brown
Journal:  Appl Microbiol       Date:  1972-12

9.  Typing of Proteus mirabilis by bacteriocin production and sensitivity as a possible epidemiological marker.

Authors:  J W Kusek; L G Herman
Journal:  J Clin Microbiol       Date:  1980-07       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.